Recruiting NCT07354048
Impact Of Thyroid Dysfunction on Liver Function Tests
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Control group, Patients with hypothyroidism or hyperthyroidism that are controlled on treatment, Patients with hypothyroidism or hyperthyroidism that are not controlled on treatment, Patients with hypothyroidism or hyperthyroidism that are firstly discovered.
- Who it may be relevant to
- Registry conditions: Thyroid Disease. Basic parameters: 20 years — 60 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Egypt
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Impact Of Thyroid Dysfunction on Liver Function Tests In Sohag University Hospital
Overview
This study aims to evaluate the effect of thyroid dysfunction on liver function tests.
Interventions
- Other Control group
Healthy people - Other Patients with hypothyroidism or hyperthyroidism that are controlled on treatment
This group includes patients with hypothyroidism or hyperthyroidism that are controlled on treatment - Other Patients with hypothyroidism or hyperthyroidism that are not controlled on treatment
This group includes patients with hypothyroidism or hyperthyroidism that are not controlled on treatment - Other Patients with hypothyroidism or hyperthyroidism that are firstly discovered
This group includes patients with hypothyroidism or hyperthyroidism that are firstly discovered
Primary outcome measures
- Measuring total bilirubin level in patients with thyroid dysfunction diseases [Time frame: 1 months]
Eligibility criteria
Inclusion criteria
- All patients between the ages of 20-60 years old either with Hypothyroidism or Hyperthyroidism (controlled on treatment or not) and firstly diagnosed Hypothyroidism or Hyperthyroidism.
- Euthyroid controls (clinically healthy control subjects were recruited from the general population with the same socio-economic status with the subjects.)
Exclusion criteria
- Patients aged < 20 years old.
- Patients With Liver Disease.
- Pregnant and lactating women.
- Patients with severe infections or sepsis.
- Patients with Heart Disease.
- Patients who on drugs that can affect liver function such as phenothiazine, phenylbutazone, methyldopa, among others.
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Case-control
Study locations
Egypt · 1 center
- Sohag University Hospital — Sohag
Publications
- Boelaert K, Franklyn JA. Thyroid hormone in health and disease. J Endocrinol. 2005 Oct;187(1):1-15. doi: 10.1677/joe.1.06131. PMID 16214936
- Malik R, Hodgson H. The relationship between the thyroid gland and the liver. QJM. 2002 Sep;95(9):559-69. doi: 10.1093/qjmed/95.9.559. PMID 12205333
- Bianco AC, Salvatore D, Gereben B, Berry MJ, Larsen PR. Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases. Endocr Rev. 2002 Feb;23(1):38-89. doi: 10.1210/edrv.23.1.0455. PMID 11844744
Identifiers
NCT: NCT07354048 · Soh-Med--25-7-9MS